BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31478369)

  • 1. Size Matters and How You Measure It: A Gram-Negative Antibacterial Example Exceeding Typical Molecular Weight Limits.
    Ruggiu F; Yang S; Simmons RL; Casarez A; Jones AK; Li C; Jansen JM; Moser HE; Dean CR; Reck F; Lindvall M
    ACS Infect Dis; 2019 Oct; 5(10):1688-1692. PubMed ID: 31478369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
    Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
    Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial evaluation of new monobactams.
    Thu ZM; Sun J; Ji J; He L; Ji J; Iqbal Z; Myo KK; Gao Y; Zhai L; Mu Y; Tang D; Vidari G; Yang H; Yang Z
    Bioorg Med Chem Lett; 2021 May; 39():127878. PubMed ID: 33636305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
    Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
    J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Kou Q; Wang T; Zou F; Zhang S; Chen Q; Yang Y
    Eur J Med Chem; 2018 May; 151():98-109. PubMed ID: 29605810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial evaluation against resistant Gram-negative bacteria of monobactams bearing various substituents on oxime residue.
    Li ZW; Lu X; Wang YX; Hu XX; Fu HG; Gao LM; You XF; Tang S; Song DQ
    Bioorg Chem; 2020 Jan; 94():103487. PubMed ID: 31831161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and antibiotic activity of monobactam analogues of nocardicins.
    Gerardin-Charbonnier C; Auberger S; Molina L; Achilefu S; Manresa MA; Vinardell P; Infante MR; Selve C
    Prep Biochem Biotechnol; 1999 Aug; 29(3):257-72. PubMed ID: 10431930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Pyridone-Conjugated Monosulfactams as Potent and Broad-Spectrum Antibiotics for Multidrug-Resistant Gram-Negative Infections.
    Tan L; Tao Y; Wang T; Zou F; Zhang S; Kou Q; Niu A; Chen Q; Chu W; Chen X; Wang H; Yang Y
    J Med Chem; 2017 Apr; 60(7):2669-2684. PubMed ID: 28287720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaching the Barrier: Quantifying Antibiotic Permeability across Gram-negative Bacterial Membranes.
    Cama J; Henney AM; Winterhalter M
    J Mol Biol; 2019 Aug; 431(18):3531-3546. PubMed ID: 30959052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting the porin pathway for polar compound delivery into Gram-negative bacteria.
    Scorciapino MA; D'Agostino T; Acosta-Gutierrez S; Malloci G; Bodrenko I; Ceccarelli M
    Future Med Chem; 2016 Jun; 8(10):1047-62. PubMed ID: 27303954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity.
    Takrouri K; Cooper HD; Spaulding A; Zucchi P; Koleva B; Cleary DC; Tear W; Beuning PJ; Hirsch EB; Aggen JB
    ACS Infect Dis; 2016 Jun; 2(6):405-26. PubMed ID: 27627629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BAL30072--an iron complexing beta lactam antibiotic against multidrug-resistant gram negative bacteria].
    Schmitz J
    Pharm Unserer Zeit; 2011 Mar; 40(2):98-9. PubMed ID: 21630531
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-kinetic relationship of carbapenem antibacterials permeating through E. coli OmpC porin.
    Tran QT; Pearlstein RA; Williams S; Reilly J; Krucker T; Erdemli G
    Proteins; 2014 Nov; 82(11):2998-3012. PubMed ID: 25082756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria.
    Pagès JM; James CE; Winterhalter M
    Nat Rev Microbiol; 2008 Dec; 6(12):893-903. PubMed ID: 18997824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of C-4 thio- and dithiocarbamate monobactam derivatives.
    Cascio G; Lorenzi L; Caglio D; Manghisi E; Arcamone F; Guanti G; Satta G; Morandotti G; Sperning R
    Farmaco; 1996 Mar; 51(3):189-96. PubMed ID: 8688141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.
    Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
    Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of monobactams and other antibiotics.
    Bakhtiar M; Selwyn S
    J Chemother; 1989 Jul; 1(4 Suppl):129-30. PubMed ID: 16312336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.